Table 3.xls (5.5 kB)
Prevalence of molecular markers of resistance to sulphadoxine, pyrimethamine and amodiaquine at post-SMC in the SMC population vs. concurrent Non-SMC patient population.
dataset
posted on 2016-09-23, 17:30 authored by Hamma Maiga, Estrella Lasry, Modibo Diarra, Issaka Sagara, Amadou Bamadio, Aliou Traore, Samba Coumare, Soma Bahonan, Boubou Sangare, Yeyia Dicko, Nouhoum Diallo, Aly Tembely, Djibril Traore, Hamidou Niangaly, François Dao, Aboubecrine Haidara, Alassane Dicko, Ogobara K. Doumbo, Abdoulaye A. DjimdePrevalence of molecular markers of resistance to sulphadoxine, pyrimethamine and amodiaquine at post-SMC in the SMC population vs. concurrent Non-SMC patient population.
